On 20 December, Allergan and Paratek Pharmaceuticals announced that the FDA accepted a New Drug Application (NDA) to review Seysara (sarecycline) for the treatment of moderate-to-severe acne vulgaris in patients nine years of age and […]
Since it became clear that monoclonal antibodies and recombinant proteins will revolutionise the pharmaceutical industry, the interests of small, medium and large pharmaceutical companies in personalised medicine has grown rapidly. Biologics are set to dominate […]
Both parties will work to a joint research plan with a focus on mechanisms related to inflammation, neuropharmacology and lung irritancy, over an initial three-year period. The work is to be co-led by AZ’ senior […]
A study by scientists at the UK’s University of East Anglia (UEA) has shown that rheumatoid arthritis drug leflunomide could be used to help treat advanced skin cancer. Performed in mice, the study demonstrated that […]
The decision comes on the back of data from a Phase III trial funded and conducted by UK group Avillion under a collaborative development agreement with the drugs giant. The BFORE (Bosutinib trial in First […]